Bioxyne (BXN:ASX) is an international life sciences and novel medicines development company with operations in Australia (head office), United Kingdom, Japan, Malaysia, Switzerland, Czechia, France and the United States serving customers world-wide.
The company’s key activity is healthcare, which is divided into two categories:
1. Pre-Pharmaceutical (Bioxyne and Breathe Life Sciences)
2. Pharmaceuticals (Wholly owned subsidiary Breathe Life Sciences)
Pre-pharma activities include development and sale of over the counter healthcare products, such as our patented probiotic strain PCC, which is sold in the United States, or our CBD (novel foods, FSA) and nootropic supplements sold in the UK, Europe, and Japan (approved and purchased by Amazon) under the Breathe Life Sciences and Dr Watson brands. Our pre-pharma development pipeline of health and wellness products allow us to bring new products to market quickly and reach commercial scale and profitability while generating observational data and customer feedback on efficacy.
BXN pharmaceutical activities are spearheaded in Australia, where our wholly owned subsidiary BLS Wholesalers is licensed to import, export, wholesale, and manufacture Schedule 3,4 and 8 poisons including medicinal cannabis and other. Our manufacturing facility in Brisbane is undergoing a TGA GMP audit in 2023, following which we hope to manufacture medicines for the Australian and international markets.
Bioxyne’s distribution capabilities are global. With teams on the ground in 4 continents, we work with over 1000 corporate customers supplying bulk materials, starting materials, APIs, white label finished products, and branded products to customers world-wide.
For wholesale enquiries in Australia please get in touch here
For wholesale enquiries in rest of world please get in touch here
GMP & GACP COMPLIANT STARTING MATERIALS
We work with dozens of cultivators, manufacturers, and suppliers of starting materials and APIs in the EU, Americas, South Africa and Switzerland. Leverage our relationships to access the best quality and pricing, and rely on us to support your business needs.
Certificates of analysis and compliance documentation available on enquiry.
The Therapeutic Goods Agency requires all APIs to adhere to GMP standards in Australia. We work with GMP-certified extraction labs in the EU, South Africa, and the Americas to supply compliant highest quality extracts to licensed wholesale customers in Australia.
If you have manufacturing or compounding needs in Australia, please get in touch
Working with Instant Scripts, the leading telemedicine provider in Australia, we provide patient access to consultations with special access approved doctors in Australia. Through this service patients can book an appointment online and speak to one of our doctors same day to discuss their needs privately and securely.